Associate Professor
Chair
B.S. Pharmacy, University of San Carlos, 2011
M.S. Pharmacy, University of San Carlos, 2015
Ph.D. Pharmaceutical and Health Sciences, Josai University, 2020
Topical and cosmetic formulations, nanocarrier drug delivery
1. Sakdiset, P.; Arce, F.; See, G. L.; Sawatdee, S.; Sae Yoon, A. (2023). Preparation and characterization of lidocaine HCl-loaded proniosome gels with skin penetration enhancers. J. Drug Delivery Sci. Technol., 86. doi: 10.1016/j.jddst.2023.104639
2. Inoue, Y.; Nanri, A.; Arce, F. Jr.; See, G. L.; Tanikawa, T.; Yokogawa, T.; Kitamura, M. (2023). Preparation and spectroscopic characterization of ternary inclusion complexes of ascorbyl palmitate and urea with γ-cyclodextrin. Chem. Engineer., 7(2), 29. doi: 10.3390/chemengineering7020029
3. Sakurai, H.; Suzuki, M.; Itakura, S.; Todo, H.; Arce, F. Jr.; See, G. L.; Tanikawa, T.; Inoue, Y. (2022). Preparation, characterization, solubility, and antioxidant capacity of ellagic acid-urea complex. Materials, 15(8), 2836.
4. Tachikawa, R.; Saito, H.; Moteki, H.; Kimura, M.; Kitagishi, H.; Arce, F. Jr.; See, G. L.; Tanikawa, T.; Inoue, Y. (2022). Preparation, characterization, and in vitro evaluation of inclusion complexes formed between S-allylcysteine and cyclodextrins. ACS Omega, 7(35), 31233-31245. https://doi.org/10.1021/acsomega.2c03489
5. Liston, L. S.; Rivas, P. L.; Sakdiset, P.; See, G. L.; Arce, F. Jr. (2022). Chemical permeation enhancers for topically-applied Vitamin C and its derivatives: A systematic review. Cosmetics, 9, 85.
6. Inoue, Y.; Shigematsu, M.; Komatsu, T.; Oguchi, T.; Arce, F. J.; See, G. L. (2022). Preparation and spectroscopic characterization of inclusion complexes of 3D ball-milled rifampicin with beta-cyclodextrin and gamma-cyclodextrin. AAPS PharmSciTech, 23(5), 138.
7. Inoue, Y.; Yoshida, M.; Ezawa, T.; Tanikawa, T.; Arce, F. Jr.; See, G. L.; Tomita, J.; Suzuki, M.; Oguchi, T. (2021). Inclusion complexes of daidzein with cyclodextrin-based metal-organic-framework-1 enhance its solubility and antioxidant capacity. AAPS PharmSciTech, 23(1), 2.
8. Nanri, A.; Yoshida, M.; Ishida, Y.; Nakata, D.; Terao, K.; Arce, F. Jr.; See, G. L.; Tanikawa, T.; Inoue, Y. (2021). Preparation and characterization of a hybrid complex of cyclodextrin-based metal-organic-framework-1 and ascorbic acid derivatives. Materials, 14(23), 7309.
9. See, G. L.; Arce, F. V. J.; Dahlizar, S., Okada, A.; Fadli, MFBM; Hijikuro, S. et al. (2020). Enhanced nose-to-brain delivery of tranilast using liquid crystal formulations. J. Control. Rel. 325, 1-9.
10. See, G. L.; Arce, F. V. J.; Itakura, S.; Todo, H.; Sugibayashi, K. (2020). Prolonged distribution of tranilast in the eyes after topical application onto eyelid skin. Chem. Pharm. Bull. 68(8), 779-783.
11. Arce, F. V. J.; Asano, N.; See, G. L.; Oshizaka, T.; Itakura, S.; Todo, H.; Sugibayashi, K. (2020). Prediction of skin permeation and concentration of rhododendrol applied as finite dose from complex cosmetic vehicles. Int. J. Pharm. 119186.